BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/13/2021 8:57:47 AM | Browse: 975 | Download: 1428
Publication Name World Journal of Diabetes
Manuscript ID 69392
Country Serbia
Received
2021-06-28 17:47
Peer-Review Started
2021-06-28 17:52
First Decision by Editorial Office Director
2021-07-15 17:57
Return for Revision
2021-07-15 17:57
Revised
2021-07-24 14:49
Publication Fee Transferred
Second Decision by Editor
2021-08-06 03:17
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2021-08-06 05:57
Articles in Press
2021-08-06 05:57
Edit the Manuscript by Language Editor
2021-08-17 22:37
Typeset the Manuscript
2021-10-11 04:17
Publish the Manuscript Online
2021-10-13 08:37
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Minireviews
Article Title Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
Manuscript Source Invited Manuscript
All Author List Milica M Borovcanin, Katarina Vesic, Milena Jovanovic and Natasa R Mijailovic
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Science and Technological Development of the Republic of Serbia 175069
Faculty of Medical Sciences, University of Kragujevac JP 15-05
Corresponding Author Milica M Borovcanin, MD, PhD, Associate Professor, Department of Psychiatry, University of Kragujevac, Serbia, Faculty of Medical Sciences, 69 Svetozara Markovica St, Kragujevac 34000, Sumadija, Serbia. milicaborovcanin@medf.kg.ac.rs
Key Words Galectin-3; Schizophrenia; Metabolic syndrome; Insulin resistance; Cognition; Antipsychotics
Core Tip Atypical antipsychotic use could be associated with undesired metabolic effects. In this context, glycosylation has become a new target of investigation of schizophrenia pathophysiology. As a glycan, galectin-3 (Gal-3) might be involved in the inflammation-insulin resistance-obesity cascade in schizophrenia, leading to cognitive changes. Eliminating Gal-3 influence may be beneficial in preserving cognition and reestablishing metabolic balance.
Publish Date 2021-10-13 08:37
Citation Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739
URL https://www.wjgnet.com/1948-9358/full/v12/i10/1731.htm
DOI https://dx.doi.org/10.4239/wjd.v12.i10.1731
Full Article (PDF) WJD-12-1731.pdf
Full Article (Word) WJD-12-1731.docx